Patent details

Basic Information

Publication number:

EP3333264

PCT Application Number:

KR2016008632

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP168333748

PCT Publication Number:

WO2017023138

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

CHIMERIC ANTIGEN RECEPTOR, AND T CELLS IN WHICH CHIMERIC ANTIGEN RECEPTOR IS EXPRESSED

French Title of Invention:

RÉCEPTEUR D'ANTIGÈNES CHIMÈRE ET LYMPHOCYTES T DANS LESQUELS LE RÉCEPTEUR D'ANTIGÈNES CHIMÈRE EST EXPRIMÉ

German Title of Invention:

CHIMÄRER ANTIGENREZEPTOR UND T-ZELLEN, IN DENEN DER CHIMÄRE ANTIGENREZEPTOR EXPRIMIERT WIRD

SPC Number:

Dates

Filing date:

05/08/2016

Grant date:

31/03/2021

EP Publication Date:

13/06/2018

PCT Publication Date:

09/02/2017

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

31/03/2021

EP B1 Publication Date:

31/03/2021

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

05/08/2021

Expiration date:

05/08/2036

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

24/03/2021

 

 

Name:

CellabMED Inc.

Address:

No 1301-1, 38-21, Digital-ro 31-gil, Guro-gu, Seoul, Korea (Republic) (KR)

Inventor

Name:

KONG, Seogkyoung

Address:

Korea (Republic) (KR)

Priority

Priority Number:

20150110788

Priority Date:

05/08/2015

Priority Country:

Korea (Republic) (KR)

Classification

IPC classification:

C07K 16/24; C07K 19/00; C12N 15/62; C12N 15/85; A61K 35/17;

Publication

European Patent Bulletin

Issue number:

202113

Publication date:

31/03/2021

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages